Mr. Aaron is an attorney in the U.S. Department of Justice National Security Division, Office of Law and Policy. His responsibilities include biosecurity and security screening policy, among other areas.
Mr. Aaron has worked on a variety of legal and policy matters relating to national security operations, programs, and oversight, and he served as Special Assistant United States Attorney in the Eastern District of Virginia. Prior to joining the Department of Justice in 2005, Mr. Aaron was Assistant District Attorney in Manhattan.
Mr. Aaron received his JD in 2000 from Fordham University School of Law. As a law student, he published a student Note focusing on prosecutorial ethics, served on the editorial board of the Law Review and Moot Court Board, and was a Stein Scholar in Public Interest Law and Ethics. He received his BA from the College of Social Studies at Wesleyan University in 1995.
Dr. Appler is a Science and Technology Policy Fellow with the American Association for the Advancement of Science, and she works for the Chemical and Biological Defense Division of the Department of Homeland Security’s Science and Technology Directorate. Her fellowship is focused on developing the next generation of environmental biosurveillance technology. This includes supporting existing programs, participating in interagency work addressing biological detection technologies, and documenting the critical requirements for environmental biosurveillance to lead to rapid response at the federal, state, and local levels. Her biosecurity interests include pandemic and infectious disease threat agents, all-hazards emergency response and preparedness, synthetic biology and other dual-use research areas, and cutting-edge technology development, adaptation, and testing for biosecurity applications.
Prior to beginning her fellowship, Dr. Appler completed a short postdoctoral fellowship and earned her PhD in neurobiology at Harvard Medical School. Her research used molecular biology and systems-level genetic analysis to understand how the auditory system develops normally, and how this pattern of development is disrupted in some hereditary deafness syndromes. She received a BS in biochemistry from the University of Southern California, with a minor in architecture.
Mr. Ayscue is graduating from Cornell University’s College of Veterinary Medicine in May, where he will remain for another year to complete a PhD in epidemiology. His dissertation research uses mathematical models to study the transmission and propagation of zoonotic diseases, with an emphasis on indirectly transmitted pathogens.
After receiving a degree in biology and environmental studies from Emory University, he worked with the Wildlife Conservation Society in Cambodia under the auspices of the Luce Scholars Program, studying the impact of wild and domestic animal health on conservation efforts in the region and establishing surveillance networks for avian influenza virus. He has also worked as a visiting scientist at the Pasteur Institute, studying a large hepatitis C epidemic in Egypt, and he is currently completing a fellowship at the National Academy of Sciences in Science and Technology Policy. Mr. Ayscue anticipates applying his experience to a career in protecting the public health and ensuring biosecurity.
Dr. Bumpus is a science and technology policy fellow with the American Association for the Advancement of Science, and she works in the Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs at the U.S. Department of Defense (DoD). She currently serves in the OASD/NCB-Office of Threat Reduction and Arms Control, supporting the DoD Cooperative Biological Engagement Program. In this role, Dr. Bumpus works in the area of global health security, with a regional focus on sub-Saharan Africa and India. Dr. Bumpus works with U.S. government departments and agencies, international organizations, and partner country governments to strengthen human and animal health programs and ensure partner countries are safe from biological threats, whether naturally occurring or of intentional release.
Dr. Bumpus received a BS in chemistry from the University of Louisville (KY) in 2005, graduating summa cum laude. Prior to beginning her fellowship, Dr. Bumpus earned a PhD in chemistry in December 2009 at the University of Illinois at Urbana-Champaign IL), studying the biosynthesis of microbial natural products. She has published in the areas of biochemistry, microbiology, and analytical chemistry and has presented her research at multiple national and international meetings.
Dr. Carter is a Program Officer for the Biosecurity Engagement Program at the U.S. Department of State. In this role, Dr. Carter oversees health security programs to reduce biological risks in South and Southeast Asia. Dr. Carter works closely with foreign counterparts, the U.S. Government interagency, Non-governmental Organizations, and International Organizations to implement programs that strengthen global biosecurity.
Dr. Carter came to the State Department as a Science and Technology Policy Fellow through the American Association for the Advancement of Science. Prior to starting her tenure at the State Department, she received a Ph.D. in Cell and Developmental Biology at Vanderbilt University, where she studied intracellular transport during early development. She also holds a B.S. in Neuroscience with a minor in Spanish from Vanderbilt University. Dr. Carter’s interests include international disease surveillance, science diplomacy, global health security, and dual-use technologies.
Ms. Cavitt is Senior Associate in PricewaterhouseCoopers’ Washington Federal Practice Advisory group. Her primary expertise is in biological attack response and recovery analysis for government and private sector clients. Her work has aided a number of clients in improving biological response processes, including antibiotic prepositioning strategies, biodefense framework development, and overall end-to-end response and recovery planning. She has also been a thought leader in the area of biosurveillance and has an interest in improving intelligence and interdiction capabilities.
In addition to her U.S. biodefense efforts, she has experience working in the international public health and nonprofit sectors. Prior to joining PwC, Ms. Cavitt was with Scitor Corporation, where she conducted a biosurveillance program review for a government agency and served as Executive Secretary for a panel’s Strategy on Countering Biological Threats. She also performed a number of studies on human performance modification for the Office of the Secretary of Defense for Net Assessment.
Ms. Cavitt received a BS in biology from Furman University and a master’s degree in biohazardous threat agents and emerging infectious diseases from Georgetown University.
Ms. Fowlkes is a graduate student at the University of Alabama at Birmingham in the School of Public Health, where she will earn her MPH in May 2012. Her curriculum focus is in emergency management and disaster preparedness policy in the healthcare organization and policy department. She is also employed at Biolife Plasma Services, a division of Baxter Bioscience that focuses on providing life-saving therapies to patients with immune disorders.
Ms. Fowlkes earned a BS in biology from Alabama State University in 2007, where she was a Minority Access to Research Careers (MARC/U*STAR) scholar. Her undergraduate research focus was on the characterization of myosin light chain kinase isoforms in intestinal epithelial cells and their role in bacterial infections. She won Alabama State University’s Student of the Year award in the department of biological sciences (2002 to 2007).
Ms. Fowlkes was a Ronald E. McNair scholar at the University of Alabama at Birmingham in 2006, where she conducted research on a new method for dissection of virulence pathways by monitoring protein-protein interactions in Mycobacterium tuberculosis. In fall 2012, she will attend Howard University School of Law, where she plans to focus on legal aspects of international health relations, national security, and foreign policy.
Dr. Grant received her bachelor’s degrees in chemistry and business economics and management from the California Institute of Technology. She graduated with a PhD in experimental pathology and an MPH in epidemiology from the University of Texas Medical Branch, where her studies focused on viral hemorrhagic fevers under the direction of Dr. CJ Peters. Her research involves work in a biosafety level (BSL)-4 laboratory, the highest level of containment. Her interests in biosecurity involve dual-use research as well as select agent rules and regulations. Her work has involved international field studies in remote locations in South America.
Mr. Habib is an emerging leader with a passion for global health, social justice issues and fostering coalitions that empower others to improve their lives. He is currently an ASPH/CDC Allan Rosenfield Global Health Fellow with CDC Zambia, where he is focusing on Global Program Management.
Prior to joining CDC Zambia, Mr. Habib worked as a Policy Support Officer at the Office of the U.S. Global AIDS Coordinator at the U.S. Department of State and a Communications Specialist for an international development consulting company and as an Analyst at a state public health nonprofit organization, supporting public health preparedness and hospital preparedness policy initiatives and program activities.
He earned an MPH with a concentration in international health from the Boston University School of Public Health in 2007, and he received a BS in health policy and administration from the University of North Carolina at Chapel Hill. As a public health professional, he has experience in a diverse range of health policy issues on the local, state, national, and global level, from HIV/AIDS, to health disparities and minority health, to injury prevention and control, to refugee health and human rights. This professional background has enabled Mr. Habib to develop an interest in exploring the synergy between global health and biosecurity, particularly in the policy arena.
Ms. Hagen works in the Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs. She currently works on Cooperative Threat Reduction Oversight in the OASD(NCB)-Office of Threat Reduction and Arms Control. Her area of responsibility includes biological and chemical cooperative threat reduction activities as well as biosurveillance efforts.
Previously, Ms. Hagen was a Presidential Management Fellow in the Office of Program Analysis and Evaluation at the Department of Homeland Security. She also served as an intern in the Center for Strategic and International Studies' Homeland Security and Counterterrorism Program. She earned an MS in biohazardous threat agents and emerging infectious diseases from Georgetown University and a BA in biochemistry from Occidental College. Prior to graduate school, she conducted laboratory research at City of Hope in Duarte, CA, and at the University of Leiden in the Netherlands, and she co-authored 5 peer-reviewed articles in biochemistry and molecular biology. Ms. Hagen is interested in a range of biosecurity topics, including international efforts to reduce the risk of infectious diseases, legal issues related to biosecurity, and the implications of advancements in synthetic biology.
Dr. Hall is a biodefense analyst with the Biodefense Knowledge Center at Lawrence Livermore National Laboratory (LLNL), where she researches, develops, and writes in-depth threat- and capability-based technical assessments and awareness bulletins that are focused on the technical analysis of the dual-use potential of emerging biotechnologies.
Prior to joining the Biodefense Knowledge Center, Dr. Hall completed a postdoctoral fellowship at LLNL, where her research focused on bioprospecting of an acid and heat tolerant bacterial community for novel enzymes of industrial importance including cellulases and lipases. In 2002, Dr. Hall was awarded a post-baccalaureate Intramural Research Training Award fellowship at the National Institutes of Health in Bethesda, MD.
She earned a PhD in microbiology and immunology from Stanford University. Her dissertation research focused on the identification of proteins involved in the invasion of host cells by the protozoan parasite, Toxoplasma gondii. She received a BA in biology, with honors, from West Virginia University in 2002.
Dr. Kelley is a research associate for the BioWatch program and is Preparedness Program Coordinator at the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota. He researches, writes, and updates overviews on potential agents of bioterrorism and works on pandemic preparedness, focusing his research on vaccines and on supply chain vulnerabilities. He is passionate about preparing for emerging infectious disease threats and ensuring that the public health policy for those threats is evidence based.
Prior to his current position, Dr. Kelley was a research assistant at CIDRAP and served as Assistant Project Director on the CIDRAP Comprehensive Influenza Vaccine Initiative. He also is a member of the University of Minnesota’s Medical Reserve Corp.
Dr. Kelley earned a PhD in environmental health in 2011—his thesis evaluated the public health impact of influenza vaccines—and an MS in environmental health in 2008—with a thesis on the cascading impacts of a severe pandemic on electrical power in the United States—both from the University of Minnesota. He has a BA in biology from Luther College, where he did research on the effect of calcium on the capsular polysaccharides levels of Vibrio parahaemolyticus.
Dr. Martinez is President and CEO of Xyrion Medical, a biomedical consulting firm and provider of preventive, occupational, and travel medicine services in Puerto Rico. He is also a clinical instructor at the Ponce School of Medicine. As part of his clinical responsibilities, Dr. Martinez is actively involved in the tuberculosis and infectious diseases screening program headed by the Puerto Rico Health Department.
He completed his residency in occupational and environmental medicine at the University of Pennsylvania. Dr. Martinez obtained both his MD and MPH from the Ponce School of Medicine. In addition to English, he speaks fluent Spanish and basic Mandarin and Farsi. His primary interests in biosecurity relate to the technological advances, regulations, and accessibility of information that could grant hostile parties access to a wider array of biological weapons.
Dr. Montague is Staff Scientist in the Synthetic Biology and Bioenergy department of the J. Craig Venter Institute (JCVI) in Rockville, MD, where his current work involves proteomics to support the minimal-genome project, efforts to extend the methods used in the synthetic cell to non-Mycoplasma, and use of synthetic biology techniques in drug discovery. Dr. Montague worked on several aspects of the 2010 effort to create a synthetic cell, including quality control work to confirm the sequences of the various stages of the assembly of the synthetic cell’s genome. He also designed the watermarks that were encoded into the synthetic genome and the system by which they were encoded.
Prior to joining the JCVI in 2005, he earned his doctorate in the laboratory of Clyde A. Hutchison III, studying evolution, and protein families. His dissertation title was “Functional Phylogeny of Protein Families.” He received a BS in biochemistry from the University of Dallas. Dr. Montague’s interest in biosecurity stems from a confluence of his knowledge of the emerging field of synthetic biology and his long-time fascination with military history, strategy, and tactics.
Mr. Raghuwanshi is an interdisciplinary scientist at the U.S. Food and Drug Administration, where he helped launch the Medical Countermeasures Initiative. He currently manages the MCM regulatory science project portfolio, which incorporates novel scientific advancements into the medical product review process to make product development more efficient and predictable.
Prior to joining FDA, Mr. Raghuwanshi studied taste sensation and adaptation inDrosophila at the Johns Hopkins Center for Sensory Biology; he created a grant management system at the Baltimore City Health Department; and he conducted clinical research at Premiere Oncology in southern California. He currently serves as a reviewer for the peer-reviewed journal Diabetes Technology and Therapeutics, and he has international field experience in improving rural communities’ access to health care. His interests in biosecurity include working across disciplines to develop disaster preparedness and mitigation strategies and leveraging innovative technologies to strengthen and speed up medical countermeasure development and approval.
Mr. Raghuwanshi received a BA in economics from UCLA and an MPH from Johns Hopkins University.
Dr. Rose is a policy analyst at the Center for Health & Homeland Security. He works on the Homeland Security Exercise and Evaluation Program. He also provides subject matter expertise for international delegations through the Senior Crisis Management Seminars in collaboration with the U.S. Department of State Office of Anti-Terrorism Assistance. Dr. Rose contributes expert analyses on public health–related issues and policy perspectives as an infectious disease expert. He also holds an adjunct assistant professor position at the University of Maryland School of Medicine, Department of Epidemiology and Public Health.
Dr. Rose’s tenure has included working at the National Institutes of Health and the Los Alamos National Laboratories. Most recently he was a NRSA postdoctoral fellow at the University of Pennsylvania. His research focused on understanding the biology of insect-transmitted viruses, which are a serious public health burden causing morbidity and mortality worldwide.
Dr. Rose speaks German and French, and he was named in 2011 to the top 100 International Academics by the German Scholars Organization and the President of Germany. He holds a BS in biological sciences from Clemson University, and a PhD in microbiology and immunology from Oregon Health & Sciences University.
Ms. Rubin is a program analyst at the National Association of County and City Health Officials (NACCHO). She serves as project lead and manages day-to-day tasks at NACCHO for the Alternative Methods for Antiviral Dispensing Project and the Nurse Triage Line Project, two CDC-funded initiatives that explore various models to more efficiently and effectively distribute and dispense antiviral medication to the public during a pandemic.
Prior to her position with NACCHO, Ms. Rubin served as assistant director of research at the Bipartisan WMD Terrorism Research Center where she collaborated with advisors to research and write sections of a Bio-Response Report Card. She gained policy and communications experience while at the Presidential Oil Spill Commission and the Commission on the Prevention of WMD Proliferation and Terrorism. While at FEMA, she focused on the interagency planning effort to dispense medical countermeasures after an anthrax attack.
Ms. Rubin earned an MPH and an MA in international affairs at The George Washington University in 2011. She co-authored a manuscript entitled “Effectiveness of mHealth Behavior Change Communication Interventions in Developing Countries: A Systematic Review of the Literature,” which was published June 2012 in the Journal of Health Communication. She received a BA/BS in political science and journalism, magna cum laude, from the University of Florida. In 2008, she served as a Gubernatorial Fellow at the Florida Division of Emergency Management. Ms. Rubin’s primary interest in biosecurity lies in public health preparedness and leveraging community resilience.
Yuliya Seldina is a doctoral candidate at the Uniformed Services University of the Health Sciences, where she is conducting research on emerging infectious diseases—specifically, she is investigating the progression of the infection in vivo of Bacillus anthracis in Dr. Alison O’Brien’s laboratory.
Prior to attending graduate school, Ms. Seldina worked as an intern analyst for the Center for Biosecurity of UPMC, where she conducted research in support of center projects. Ms. Seldina earned an MPH in infectious disease and microbiology at the University of Pittsburgh. Her thesis focused on the effect of FDA-approved organic compounds on Mycobacterium tuberculosis—specifically, she investigated the effect of EGCG and its potential as a therapeutic. She received a BS in microbiology from Wagner College in 2009; her thesis work explored the impact of oscillating magnetic/electrical fields on human pathogens. While receiving her BS, she was certified as a lead-based paint inspector and was charged with performing testing in New York City public schools.
Ms. Seldina immigrated to the United States in 2001 from Lithuania and is fluent in both Russian and Lithuanian. With her strong background in infectious disease and public health, Ms. Seldina would like to pursue work in intelligence and/or biosecurity policy and guidelines.
Mr. Siow is a program coordinator for the department of international health at Georgetown University. He manages the Practical Experience Abroad Program, where he supervises undergraduate students conducting social science and policy-based international health research at health institutions around the world, and coordinates logistical support with host institutions and collaborating researchers. Mr. Siow also serves as a research assistant, with a focus on global health and international development.
In addition to his roles in the international health department, Mr. Siow is a consultant for the World Bank, assisting with the review of a public-private global health program. He is currently pursuing an MS degree in biohazardous threat agents and emerging infectious diseases at Georgetown University, where he is focusing on global health security, national biosecurity, and infectious disease agents. He obtained a BS in international health from Georgetown University in 2009. As an undergraduate, he researched the health, socioeconomic, and educational disparities and challenges faced by Aborigines living on Palm Island, and he presented culturally appropriate, sector-wide approaches to improve public health in the community as part of the Australian government-funded Palm Island Project.
Ms. Smith is a member of the technical staff in the International Biological Threat Reduction (IBTR) program at Sandia National Laboratories, where she helps implement U.S. Cooperative Threat Reduction Program initiatives within Southeast Asia, leads engagements with China and Indonesia, and is deputy on engagements in Malaysia and the Philippines.Ms. Smith manages IBTR’s internal database, and she is assisting in the development of similar databases for the International Chemical Threat Reduction program and the International Nuclear Threat Reduction program. In this capacity, she facilitates the technological coordination between the databases and analytical projects and models on which she is involved. She is also involved with several laboratory-directed research and development proposals.
Ms. Smith earned a master’s degree in biohazardous threat agents and emerging infectious diseases from Georgetown University, and a bachelor’s degree in both Chinese language and art history from Williams College.
Dr. Thomason is a Senior Analyst in the U.S. Department of Defense. His group focuses broadly on two main areas: emerging and disruptive medical technologies and countermeasures for important infectious diseases and CBRN agents. Previously, he was a scientist at the Naval Medical Research Center, where he studied genomics of biodefense-relevant pathogens in Dr. Timothy Read’s group. In 2005, Brendan earned a PhD in microbiology and immunology from the University of Michigan. His dissertation research was performed in the lab of Dr. Philip Hanna and focused on the pathogenesis of Bacillus anthracis. He received a BS in microbiology from Indiana University in 1999. Brendan’s interest in biosecurity traces back to his experiences with the Department of Defense’s Cooperative Threat Reduction program. During that time, he came to appreciate the potential rewards of science diplomacy, and he looks forward to engaging on that issue, as well as on general public health, in the future.
Mr. Treubrodt is a Science and Technology Analyst within the Weapons of Mass Destruction Directorate of the FBI; his work focuses on assessment of emerging biotechnology and biosecurity issues. Mr. Treubrodt holds a master's degree in strategic intelligence from the National Intelligence University, with a thesis that focused on the analysis of amateur biology groups as model system for assessing broader biosecurity issues and biotechnology developments. Mr. Treubrodt also serves as a Fellow within the Program for Emerging Leaders at the Center for the Study of WMD at the National Defense University.
Prior to joining the FBI, Mr. Treubrodt worked as a contract toxicologist and consultant for the Environmental Protection Agency, where he assisted the Risk Assessment Division within the Office of Pollution Prevention and Toxics. Mr Treubrodt earned his first master’s degree in biotechnology with a biodefense concentration in spring 2007 from the Johns Hopkins University. He received a bachelor’s degree in biophysics in 2005, also from Johns Hopkins University. As an undergraduate, he served as a Woodrow Wilson Undergraduate Fellow, researching and publishing on thermodynamics of protein-protein interactions within bacterial cell membranes.
Dr. Wegrzyn is a lead associate at Booz Allen Hamilton, where she founded and now leads a small team of PhD biologists who provide scientific and strategic support to several government clients—including the Defense Advanced Research Projects Agency—in the areas of biodefense, biosecurity, disruptive technologies, emerging infectious diseases, and synthetic biology.
Prior to joining Booz Allen, Dr. Wegrzyn developed multiplex immunoassays and peptide-based disease diagnostics for neurodegenerative diseases in the biotech industry, and she co-edited the forthcoming text Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies. As an Alexander von Humboldt postdoctoral fellow in Heidelberg, Germany, she studied de novo protein folding at the ribosome, and she learned to speak German, earning the Zertifikat Deutsch.
She earned a PhD in applied biology (minor in bioengineering) in 2003 from Georgia Tech, where she studied the propagation of prion proteins. Dr. Wegrzyn is thrilled to be selected as an Emerging Leader in Biosecurity Fellow in the inaugural year of the program, and intends to use the award to identify new opportunities where rapid discovery and innovation in commercial, pharmaceutical, and biotech sectors can be leveraged to protect our national security interests while simultaneously providing novel protections for intellectual property.
Mr. White is Bioterrorism Defense Coordinator for the Miami Bureau of Laboratories, Florida Department of Health. As part of the Laboratory Response Network, the laboratory performs rapid and confirmatory testing for suspected agents of bioterrorism, both clinical and environmental, in southern Florida. As part of his duties, Mr. White works with hospital sentinel laboratories, first responders, and law enforcement agencies to help ensure that the laboratory is prepared to respond to an act of bioterrorism in the region. Mr. White also is responsible for laboratory influenza surveillance, rapid screening for tuberculosis, and screening food for contamination with biothreat agents.
Before joining the Bureau of Laboratories, Mr. White was a senior microbiologist with the South Dakota State Public Health Laboratory, where he worked with molecular diagnostic assays, tuberculosis identification, and pulsed-field gel electrophoresis.
He earned both a bachelor’s degree in clinical laboratory science and a master’s degree in clinical practice management from Texas Tech University Health Sciences Center in Lubbock, Texas. His interest in biosecurity lies in the realm of public health preparedness and response to incidents of bioterrorism or naturally occurring pandemics. Because of the unique nature of the public health laboratory, he is also interested in the federal regulation and oversight of select agent laboratories.
Ms. Yassif is a doctoral candidate in the biophysics group at UC Berkeley. For her thesis research, she is using fluorescence microscopy to study the nuclear pore complex, which controls the transport of materials between the cytoplasm and nucleus in eukaryotic cells.
Prior to her graduate work, Ms. Yassif worked for several years in science and security policy at the Federation of American Scientists, where she contributed to the writing of Senate Foreign Relations Committee testimony on radiological weapons, and at the Nuclear Threat Initiative, where she organized an international workshop on Global Best Practices in Nuclear Materials Management. This was followed by a fellowship to study China’s nuclear posture at Tsinghua University in Beijing.
Ms. Yassif holds an MA in science and security from the War Studies Department at King's College London, where she wrote her thesis on verification of the Biological Weapons Convention. She received a BA in biology from Swarthmore College. Ms. Yassif’s biosecurity interests include evaluating the efficacy of microbial forensics as a tool for bioterrorism prevention and working with practitioners in Asia to enhance international biosecurity cooperation. She speaks Hebrew, Chinese, and French.